{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:28:32Z","timestamp":1780050512931,"version":"3.53.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T00:00:00Z","timestamp":1465257600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Pfizer Inc"},{"name":"Asteras Co"},{"name":"Takeda Pharm Co"},{"name":"Boehringer-Ingelheim Japan Co"},{"name":"Daiichi-Sankyo Co"},{"name":"MSD Co"},{"name":"Mochida Pharm Co"},{"name":"Novartis Pharm Co"},{"name":"DaiNihon-Sumitomo Co"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s13730-016-0223-4","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T06:58:25Z","timestamp":1465282705000},"page":"192-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A case of acquired lecithin:cholesterol acyltransferase deficiency with sarcoidosis that remitted spontaneously"],"prefix":"10.1007","volume":"5","author":[{"given":"Tanino","family":"Akiko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Okura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Kukida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijiro","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitsuo","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Bujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,7]]},"reference":[{"key":"223_CR1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clinbiochem.2014.08.014","volume":"48","author":"R Saeedi","year":"2015","unstructured":"Saeedi R, Li M, Frohlich J. A review on lecithin:cholesterol acyltransferase deficiency. Clin Biochem. 2015;48:472\u20135.","journal-title":"Clin Biochem"},{"key":"223_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/00365516709076948","volume":"20","author":"KR Norum","year":"1967","unstructured":"Norum KR, Gjone E. Familial plasma lecithin: cholesterol acyltransferase deficiency. Scand J Clin Invest. 1967;20:31\u2013243.","journal-title":"Scand J Clin Invest"},{"key":"223_CR3","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1194\/jlr.R024513","volume":"53","author":"S Kunnen","year":"2012","unstructured":"Kunnen S, Van EM. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis. J Lipid Res. 2012;53:1783\u201399.","journal-title":"J Lipid Res"},{"key":"223_CR4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5551\/jat.11.131","volume":"11","author":"T Maruyama","year":"2004","unstructured":"Maruyama T, Yamashita S, Matsuzawa Y, Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan, et al. Mutations in Japanese subjects with primary hyperlipidemia: results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996. J Atheroscler Thromb. 2004;11:131\u201345.","journal-title":"J Atheroscler Thromb"},{"key":"223_CR5","first-page":"299","volume":"4","author":"A Katayama","year":"2011","unstructured":"Katayama A, Wada J, Kataoka UH, et al. Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations. NDT Plus. 2011;4:299\u2013302.","journal-title":"NDT Plus"},{"key":"223_CR6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.5551\/jat.5488","volume":"17","author":"S Hirashio","year":"2010","unstructured":"Hirashio S, Izumi K, Ueno T, et al. Point mutation (C to T) of the LCAT gene resulting in A140C substitution. J Atheroscler Thromb. 2010;17:1297\u2013301.","journal-title":"J Atheroscler Thromb"},{"key":"223_CR7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2012090913","volume":"24","author":"S Takahashi","year":"2013","unstructured":"Takahashi S, Hiromura K, Tsukida M, et al. Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency. J Am Soc Nephrol. 2013;24:1305\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"223_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-024911-4.50008-8","volume":"11","author":"JA Glomset","year":"1973","unstructured":"Glomset JA. The metabolic role of lecithin:cholesterol acyltransferase: perspectives from pathology. Adv Lipid Res. 1973;11:1\u201365.","journal-title":"Adv Lipid Res"},{"key":"223_CR9","first-page":"167","volume":"10","author":"E Gjone","year":"1981","unstructured":"Gjone E. Familial lecithin:cholesterol acyltransferase deficiency\u2014a new metabolic disease with renal involvement. Adv Nephrol Necker Hosp. 1981;10:167\u201385.","journal-title":"Adv Nephrol Necker Hosp"},{"key":"223_CR10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcm.2010.03.007","volume":"20","author":"L Calabresi","year":"2010","unstructured":"Calabresi L, Franceschini G. Lecithin: cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans. Trends Cardiovasc Med. 2010;20:50\u20133.","journal-title":"Trends Cardiovasc Med"},{"key":"223_CR11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1399-0004.1972.tb01458.x","volume":"3","author":"H Torsvik","year":"1972","unstructured":"Torsvik H. Studies on the protein moiety of serum high density lipoprotein from patients with familial lecithin: cholesterol acyltransferase deficiency. Clin Genet. 1972;3:88\u2013200.","journal-title":"Clin Genet"},{"key":"223_CR12","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/ATVBAHA.114.303420","volume":"34","author":"M Kuroda","year":"2014","unstructured":"Kuroda M, Holleboom AG, Stroes ES, et al. Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency. Arterioscler Thromb Vasc Biol. 2014;34:1756\u201362.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"223_CR13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0021-9150(93)90191-V","volume":"104","author":"M Guerin","year":"1993","unstructured":"Guerin M, Dolphin PJ, Chapman MJ. Familial lecithin:cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval. Atherosclerosis. 1993;104:195\u2013212.","journal-title":"Atherosclerosis"},{"key":"223_CR14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5414\/CN106484","volume":"76","author":"K Shoji","year":"2011","unstructured":"Shoji K, Morita H, Ishigaki Y, et al. Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review. Clin Nephrol. 2011;76:323\u20138.","journal-title":"Clin Nephrol"},{"key":"223_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2011.661","volume":"172","author":"S Simonelli","year":"2012","unstructured":"Simonelli S, Gianazza E, Mombelli G, et al. Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin: cholesterol acyltransferase in non-Hodgkin lymphoma. Arch Intern Med. 2012;172:179\u201381.","journal-title":"Arch Intern Med"},{"key":"223_CR16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014;383:1155\u201367.","journal-title":"Lancet"},{"key":"223_CR17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10157-013-0895-4","volume":"18","author":"S Hirashio","year":"2014","unstructured":"Hirashio S, Ueno T, Naito T, et al. Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency. Clin Exp Nephrol. 2014;18:189\u201393.","journal-title":"Clin Exp Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-016-0223-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-016-0223-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-016-0223-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:36:35Z","timestamp":1718624195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-016-0223-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["223"],"URL":"https:\/\/doi.org\/10.1007\/s13730-016-0223-4","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,7]]}}}